Caffeine-containing medicines increase the risk of hemorrhagic stroke

Stroke

Volumn 44, Issue 8, 2013, Pages 2139-2143

  Lee, Seung Mi ^a   Choi, Nam Kyong ^b,c   Lee, Byung Chul ^d   Cho, Ki Hyun ^e   Yoon, Byung Woo ^c   Park, Byung Joo ^b,c  

^a Chung Ang University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Hallym University College of Medicine   (South Korea)

^e Chonnam National University Medical School   (South Korea)

Author keywords

caffeine; case control studies; cerebral hemorrhage; subarachnoid hemorrhage

Indexed keywords

CAFFEINE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH KOREA; SUBARACHNOID HEMORRHAGE;

CAFFEINE; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; CAFFEINE; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REPUBLIC OF KOREA; RISK; STROKE; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 84880792933     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.674077     Document Type: Article

References (27)

1. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992;17:139-170.
2. Carrillo JA, Benitez J. Clinically signifcant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39:127-153.
3. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990;323:1026-1032. (Pubitemid 20336961)
4. Hakim AA, Ross GW, Curb JD, Rodriguez BL, Burchfel CM, Sharp DS, et al. Coffee consumption in hypertensive men in older middle-age and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol. 1998;51:487-494. (Pubitemid 28310236)
5. Bidel S, Hu G, Qiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia. 2006;49:2618-2626. (Pubitemid 44559523)
6. Larsson SC, Männistö S, Virtanen MJ, Kontto J, Albanes D, Virtamo J. Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke. 2008;39:1681-1687.
7. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, van Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009;119:1116-1123.
8. Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol. 2011;174:993-1001.
9. Liang W, Lee AH, Binns CW, Huang R, Hu D, Zhou Q. Tea consumption and ischemic stroke risk: a case-control study in southern China. Stroke. 2009;40:2480-2485.
10. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke. 2009;40:1786-1792.
11. Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, et al.; Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifable. Stroke. 2003;34:1375-1381. (Pubitemid 36693501)
12. Feldmann E, Broderick JP, Kernan WN, Viscoli CM, Brass LM, Brott T, et al. Major risk factors for intracerebral hemorrhage in the young are modifable. Stroke. 2005;36:1881-1885. (Pubitemid 41266519)
13. Yoon BW, Bae HJ, Hong KS, Lee SM, Park BJ, Yu KH, et al.; Acute Brain Bleeding Analysis (ABBA) Study Investigators. Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke. Neurology. 2007;68:146-149. (Pubitemid 46071900)
14. Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832. (Pubitemid 32104127)
15. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997;37:693-703. (Pubitemid 27449278)
16. Brown NJ, Ryder D, Branch RA. A pharmacodynamic interaction between caffeine and phenylpropanolamine. Clin Pharmacol Ther. 1991;50:363-371.
17. Lake CR, Rosenberg DB, Gallant S, Zaloga G, Chernow B. Phenylpropanolamine increases plasma caffeine levels. Clin Pharmacol Ther. 1990;47:675-685. (Pubitemid 20207324)
18. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838. (Pubitemid 32104128)
19. Vahedi K, Domigo V, Amarenco P, Bousser MG. Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building. J Neurol Neurosurg Psychiatry. 2000;68:112-113. (Pubitemid 30248682)
20. Zahn KA, Li RL, Purssell RA. Cardiovascular toxicity after ingestion of "herbal ecstacy". J Emerg Med. 1999;17:289-291. (Pubitemid 29136149)
21. Fallis RJ, Fisher M. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Neurology. 1985;35:405-407. (Pubitemid 15100685)
22. Kase CS, Foster TE, Reed JE, Spatz EL, Girgis GN. Intracerebral hemorrhage and phenylpropanolamine use. Neurology. 1987;37:399-404. (Pubitemid 17031734)
23. Glick R, Hoying J, Cerullo L, Perlman S. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. Neurosurgery. 1987;20:969-974. (Pubitemid 17113139)
24. Choi NK, Park BJ, Jeong SW, Yu KH, Yoon BW. Nonaspirin nonste-roidal anti-infammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study. Stroke. 2008;39:845-849.
25. Kalton G, Piesse A. Survey research methods in evaluation and case-control studies. Stat Med. 2007;26:1675-1687. (Pubitemid 46455627)
26. Choi NK, Hahn S, Yoon BW, Park BJ. Potential bias caused by control selection in secondary data analysis: nonaspirin nonsteroidal anti-infammatory drugs and hemorrhagic stroke. Pharmacoepidemiol Drug Saf. 2010;19:604-609.
27. Horwitz RI, Feinstein AR, Harvey MR. Case-control research. Temporal precedence and other problems of the exposure-disease relationship. Arch Intern Med. 1984;144:1257-1259. (Pubitemid 14121079)